tm logo

Monitor this mark

View On USPTO

BOTRESO
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 22 Mar 2023

Last Applicant/ Owned by

Health Ever Bio-Tech Co., Ltd.

No. 95, Sec.1, Xintai 5th Rd, Xizhi Dist

New Taipei City

TW

221416

Serial Number

86328705 filed on 03rd Jul 2014

Registration Number

5281564 registered on 05th Sep 2017

in the Principal Register

Correspondent Address

Jen-Feng Lee

Jen-Feng Lee

17800 CASTLETON ST STE 560

CITY OF INDUSTRY, CA 91748-6801

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

BOTRESO

Pharmaceutical preparations for treating prostate diseases, cardiovascular diseases, bone diseases, and for cancer treatment and prevention

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for treating prostate diseases, cardiovascular diseases, bone diseases, and for cancer treatment and prevention

First Use Date in General

15th Jun 2017

First Use Date in Commerce

15th Jun 2017

Mark Details

Serial Number

No 86328705

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 62732.05

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
22nd Mar 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
22nd Mar 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
21st Mar 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07th Sep 2022TEAS SECTION 8 & 15 RECEIVED
05th Sep 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05th Sep 2017REGISTERED-PRINCIPAL REGISTER
02th Aug 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01st Aug 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
13th Jul 2017STATEMENT OF USE PROCESSING COMPLETE
12th Jul 2017USE AMENDMENT FILED